Department of Interventional Radiology, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, No. 1 Banshan East Road, Hangzhou 310022, Zhejiang, China.
Biomed Pharmacother. 2019 Nov;119:109402. doi: 10.1016/j.biopha.2019.109402. Epub 2019 Sep 9.
Iodine-125 (I) irradiation has been widely applied in the treatment of advanced multiple malignant tumors. However, the underlying mechanism of I exerted an anti-tumor effect on hepatocellular carcinoma (HCC) was largely unknown.
In both HCCLM3 and SMMC-7721 cells, the effect of I irradiation on the glycolysis was detected. The mRNA in HCC tissues and cell lines were detected by RT-qPCR. Cell proliferation, invasion and migration, and apoptosis were examined by CCK-8, Transwell, wound healing assay and flow cytometry assay, respectively. The interaction between miR-338 and PFKL (6-phosphofructokinase) were verified by dual-luciferase reporter gene assay. Western blotting was used to detect the expression of glycolysis-related proteins. We also evaluated the effect of I seed implantation on the tumor growth and Warburg effect in vivo.
I irradiation significantly decreased the Warburg effect, cell proliferation, invasion and migration, and induced apoptosis of HCCLM3 and SMMC-7721 cells. miR-338 was upregulated in HCC cells treated with I irradiation, which was a negative correlation with tumor size, tumor metastasis, and tumor development. Moreover, miR-338 directly interacted with PFKL and suppressed its expression. Mechanistically, I irradiation significantly decreased the Warburg effect and exhibited anti-tumorigenesis function through upregulating the inhibitory effect of miR-338 on PFKL expression.
I irradiation upregulated the suppression of miR-338 on PFKL to downregulate the Warburg effect and anti-tumorigenesis in HCC and provided a new potential strategy for HCC clinical treatment.
碘-125(I)照射已广泛应用于治疗晚期多发性恶性肿瘤。然而,I 对肝细胞癌(HCC)发挥抗肿瘤作用的机制在很大程度上尚不清楚。
在 HCCLM3 和 SMMC-7721 细胞中,检测 I 照射对糖酵解的影响。通过 RT-qPCR 检测 HCC 组织和细胞系中的 mRNA。通过 CCK-8、Transwell、划痕愈合试验和流式细胞术分别检测细胞增殖、侵袭和迁移以及细胞凋亡。通过双荧光素酶报告基因检测验证 miR-338 与 6-磷酸果糖激酶(PFKL)之间的相互作用。通过 Western blot 检测糖酵解相关蛋白的表达。我们还评估了 I 种子植入对体内肿瘤生长和瓦博格效应的影响。
I 照射显著降低了 HCCLM3 和 SMMC-7721 细胞的瓦博格效应、细胞增殖、侵袭和迁移,并诱导细胞凋亡。在接受 I 照射的 HCC 细胞中,miR-338 上调,与肿瘤大小、肿瘤转移和肿瘤发展呈负相关。此外,miR-338 直接与 PFKL 相互作用并抑制其表达。在机制上,I 照射通过上调 miR-338 对 PFKL 表达的抑制作用,显著降低了瓦博格效应并发挥了抗肿瘤作用。
I 照射上调了 miR-338 对 PFKL 的抑制作用,从而降低了 HCC 的瓦博格效应和肿瘤发生,并为 HCC 的临床治疗提供了新的潜在策略。